Schematic shows current therapeutic options for patients with advanced prostate cancer, indicating potential role of PSMA radioligand therapy. PC = prostate cancer, ADT = androgen deprivation therapy, ARSI = androgen receptor signaling inhibitor, MMR = mismatch repair, HR = homologous recombination, ADP = adenosine diphosphate. (Information derived from [72].)